JNK News 41.43 05/22/2014 05:07:23 SPDR High Yield Bond Barclays

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR High Yield Bond Barclays Capital (JNK) 41.43 $JNK

5 ETFs for a Relaxed Retired Life - ETF News And Commentary
Sweta Killa - ZACKS - Thu Apr 03, 1:00PM CDT
Don't worry about income after retirement. These ETFs promise steady returns.

Notable ETF Inflow Detected - JNK
ETFChannel.com - Thu Apr 03, 10:29AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Barclays High Yield Bond ETF where we have detected an approximate $123.2 million dollar inflow -- that's a 1.2%...

State Street Introduces International Junk Bond ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:00AM CDT
Inside the latest fund from State Street which targets the international junk bond space.

AdvisorShares Debuts YieldPro ETF - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Mar 07, 1:00PM CST
AdvisorShares adds to active ETFs line-up. New fund to target high yield bond space and offer volatility protection.

Noteworthy ETF Inflows: JNK
ETFChannel.com - Thu Feb 20, 10:21AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Barclays High Yield Bond ETF where we have detected an approximate $235.8 million dollar inflow -- that's a 2.3%...

How Bonds Could Beat the Dow in 2014
Dan Caplinger, The Motley Fool - Motley Fool - Mon Feb 10, 11:30AM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. Most investors came into 2014 convinced of one thing: even...

No One Saw This Surprising Investment Winner Coming in 2014
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jan 25, 10:31AM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. The S&P 500 has had a bad start to 2014, with...

The Disappointing Dow Boosts Bonds -- For Now
Dan Caplinger, The Motley Fool - Motley Fool - Wed Jan 08, 11:31AM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. So far this year, the performance of the Dow Jones...

WisdomTree Launches Two High Yield Bond ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Dec 26, 9:00AM CST
Inside the latest junk bond ETFs from WisdomTree.

RMD 2013: Get It Done Within 6 Days, or You'll Pay Big
Dan Caplinger, The Motley Fool - Motley Fool - Thu Dec 26, 8:15AM CST
The biggest benefit of retirement accounts like IRAs and 401(k)s is not having to pay tax on your earnings until you withdraw money from your account. But most people who were 70 or older before June 30 of this year have to start taking money out...

HYLD: The Best Choice Among High Yield Bond ETFs? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Dec 24, 11:07AM CST
This actively managed fund could be an interesting choice for investors looking for high yield.

Three of These Bonds Belong Together
Chad Karnes - ETFG - Fri Dec 06, 9:54PM CST
The long awaited yield rise has kicked off, but thus far corporate and junk bonds have been somewhat immune. That is likely about to change as corporate debt joins the already declining Treasury and Muni bond markets.

Will Junk Bonds Bless or Curse Rest of the Market?
Chad Karnes - ETFG - Wed Oct 23, 10:17PM CDT
It is no secret that many of the equity markets are highly correlated. And when one market does not confirm the other one when it makes new price highs, it can often provide high probability trading setups. One such divergence is occurring now.

Watch High Yield Debt for Stock Market Signals
Chad Karnes - ETFG - Thu Sep 19, 6:02PM CDT
Not only is the high yield debt market smarter than the equity market, it has provided some good signals when it comes to the equity market's direction.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading